Japanese
English
- 有料閲覧
PPV購入案内
1,320円 (1,200円+税10%) こちらは、737ページから740ページの文献です。購入には医書.jp本会員登録が必要です。
会員登録完了後に改めて上記「購入サイトへ」を選択してください。
または「購入サイトへ」選択後に「購入ログイン」、「新規会員登録」の順に進んでください。
会員登録について詳しくはをご確認ください。
- Abstract 文献概要
- 1ページ目 Look Inside
- 参考文献 Reference
- サイト内被引用 Cited by
・Crohn病に合併したerosive pustular dermatosis of the scalp(EPD)を経験した.
・妊娠のため中断していた抗TNF-α抗体製剤を出産後に再開することで皮膚症状は改善した.
・インフリキシマブとアダリムマブのいずれも皮膚症状の抑制効果はみられた.
・経過中,消化器症状の再燃はなかった.
(「症例のポイント」より)
Erosive pustular dermatosis of the scalp
Aki, Ryoichi1)Amoh, Yasuyuki1) 1)Department of Dermatology, Kitasato Universty Hospital
A woman developed Crohn’s disease at the age of 23 years, for which she was treated with infliximab. At the age of 25 years, she became pregnant and discontinued treatment. At 4 months of pregnancy, she developed pustules and erosions on her scalp, for which she was referred to our hospital. Pathology evaluation of scalp tissue indicated infiltration of various inflammatory cells in the upper to middle layer of the dermis, and destruction of some hair follicles. The patient was diagnosed with erosive pustular dermatosis of the scalp. After giving birth, she resumed infliximab therapy, which resulted in quick improvement in her symptoms. Erosive pustular dermatosis did not worsen as a result of switching from infliximab to adalimumab during the subsequent course of treatment of Crohn’s disease. Her gastrointestinal symptoms remained stable over the course of the disease.

Copyright © 2019, KYOWA KIKAKU Ltd. All rights reserved.

